U.S. Market for Molecular Diagnostics, 2nd Edition

Chapter I: Executive Summary

• Background
• Scope and Methodology
• Size and Growth of Market
• Competitive Picture
• Market Trends and Factors

Chapter II: Introduction

• Background
• Diagnostics and Their Use
  • Clinical relevance
  • Scientific Limitations
  • Cost-Benefit Relationships
• Major Influencing Technologies
  • Genetics
  • Genomics
  • Proteomics

Chapter III: Molecular Diagnostics Technologies

• Background
• Amplification Technologies
• Blotting Technologies
• Electrophoretic Technologies
• Microchip Technologies
• Probe Technologies
• RNAi Analysis
• Single Nucleotide Polymorphism (SNP) Analysis

Chapter IV: Applications of Molecular Diagnostics

• The Testing Environment
  • Commercial Laboratories
  • University/Hospital Laboratories
• Blood Banking Analysis
• Cancer Diagnosis and Treatment Selection
• Genetic Diseases
• Pharmacogenetics
• Pharmacogenomics

Chapter V: The Market for Molecular Diagnostics

• Market Size and Trending
• Competitive Picture and Industry Structure
• Future Prospects
• Chapter VI: Company Profiles
• Abbott Diagnostics
• Affymetrix Inc.
• Agilent Technologies, Inc.
• Applied Biosystems Group
• Cepheid, Inc.
• Chiron Corporation
• diaDexus LLC
• Digene Corp.
• Gene Logic, Inc.
• Gen-Probe Incorporated
• Innogenetics NV
• MitoKor, Inc.
• Molecular Diagnostics, Inc.
• Myriad Genetics, Inc.
• Nanogen, Inc.
• Orchid Biosciences, Inc.
• Perkin-Elmer Corp.
• Roche Diasgnostics Division/Roche Molecular Systems
• Sangtec AB
• Visible Genetics

Chapter VII: Conclusions and Strategic Implications

APPENDIX A: Glossary

APPENDIX B: Company Names and Addresses